Given the urgent need for more comprehensive genetic profiling in advanced NSCLC, the introduction of next generation sequencing (NGS) covering different panels in the clinical setting has significantly improved the detection frequency of uncommon EGFR alterations, and the implement of NGS testing well characterizes the accurate EGFR mutation status (28, 29). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.